ITMI20031311A0 - Formulazioni per il trattamento di disturbi artrosici - Google Patents

Formulazioni per il trattamento di disturbi artrosici

Info

Publication number
ITMI20031311A0
ITMI20031311A0 IT2003MI001311A ITMI20031311A ITMI20031311A0 IT MI20031311 A0 ITMI20031311 A0 IT MI20031311A0 IT 2003MI001311 A IT2003MI001311 A IT 2003MI001311A IT MI20031311 A ITMI20031311 A IT MI20031311A IT MI20031311 A0 ITMI20031311 A0 IT MI20031311A0
Authority
IT
Italy
Prior art keywords
arthrotic
disorders
formulations
treatment
arthrotic disorders
Prior art date
Application number
IT2003MI001311A
Other languages
English (en)
Inventor
Ezio Bombardelli
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Priority to IT001311A priority Critical patent/ITMI20031311A1/it
Publication of ITMI20031311A0 publication Critical patent/ITMI20031311A0/it
Priority to US10/562,205 priority patent/US8343554B2/en
Priority to BRPI0411895A priority patent/BRPI0411895B1/pt
Priority to DK04735566T priority patent/DK1648484T3/da
Priority to PCT/EP2004/005875 priority patent/WO2005002611A1/en
Priority to KR1020057024594A priority patent/KR101119418B1/ko
Priority to NZ544400A priority patent/NZ544400A/en
Priority to AT04735566T priority patent/ATE414526T1/de
Priority to KR1020117007487A priority patent/KR20110039400A/ko
Priority to CNA2004800177557A priority patent/CN1812802A/zh
Priority to AU2004253242A priority patent/AU2004253242B2/en
Priority to EP04735566A priority patent/EP1648484B1/en
Priority to SI200430968T priority patent/SI1648484T1/sl
Priority to ES04735566T priority patent/ES2315662T3/es
Priority to RU2005140573/15A priority patent/RU2349336C2/ru
Priority to CA2530494A priority patent/CA2530494C/en
Priority to JP2006515812A priority patent/JP2007513051A/ja
Priority to DE602004017871T priority patent/DE602004017871D1/de
Priority to PT04735566T priority patent/PT1648484E/pt
Priority to PL04735566T priority patent/PL1648484T3/pl
Publication of ITMI20031311A1 publication Critical patent/ITMI20031311A1/it
Priority to IL172773A priority patent/IL172773A/en
Priority to NO20056161A priority patent/NO333877B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/76—Salicaceae (Willow family), e.g. poplar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
IT001311A 2003-06-27 2003-06-27 Formulazioni per il trattamento di disturbi artrosici. ITMI20031311A1 (it)

Priority Applications (22)

Application Number Priority Date Filing Date Title
IT001311A ITMI20031311A1 (it) 2003-06-27 2003-06-27 Formulazioni per il trattamento di disturbi artrosici.
US10/562,205 US8343554B2 (en) 2003-06-27 2004-01-06 Formulations for the treatment of arthritis conditions
PL04735566T PL1648484T3 (pl) 2003-06-27 2004-06-01 Formulacje do leczenia stanów chorobowych związanych z zapaleniem stawów
AU2004253242A AU2004253242B2 (en) 2003-06-27 2004-06-01 Formulations for the treatment of arhritis conditions
ES04735566T ES2315662T3 (es) 2003-06-27 2004-06-01 Formulaciones para el tratamiento de afecciones artriticas.
PCT/EP2004/005875 WO2005002611A1 (en) 2003-06-27 2004-06-01 Formulations for the treatment of arhritis conditions
KR1020057024594A KR101119418B1 (ko) 2003-06-27 2004-06-01 관절염 질환의 치료를 위한 제형
NZ544400A NZ544400A (en) 2003-06-27 2004-06-01 Formulations for the treatment of arhritis conditions
AT04735566T ATE414526T1 (de) 2003-06-27 2004-06-01 Zubereitungen zur behandlung von arthritischen erscheinungen
KR1020117007487A KR20110039400A (ko) 2003-06-27 2004-06-01 관절염 질환의 치료를 위한 제형
CNA2004800177557A CN1812802A (zh) 2003-06-27 2004-06-01 用于治疗关节炎病症的制剂
BRPI0411895A BRPI0411895B1 (pt) 2003-06-27 2004-06-01 formulações contendo saligenina e ácido boswélico, e seu uso
EP04735566A EP1648484B1 (en) 2003-06-27 2004-06-01 Formulations for the treatment of arhritis conditions
SI200430968T SI1648484T1 (sl) 2003-06-27 2004-06-01 Farmacevtske oblike za zdravljenje artritiäśnih stanj
DK04735566T DK1648484T3 (da) 2003-06-27 2004-06-01 Fremgangsmåde til behandling af arthritis-tilstande
RU2005140573/15A RU2349336C2 (ru) 2003-06-27 2004-06-01 Составы для лечения артритных состояний
CA2530494A CA2530494C (en) 2003-06-27 2004-06-01 Formulations for the treatment of arthritis conditions
JP2006515812A JP2007513051A (ja) 2003-06-27 2004-06-01 関節炎の状態を治療するための製剤
DE602004017871T DE602004017871D1 (de) 2003-06-27 2004-06-01 Zubereitungen zur behandlung von arthritischen erscheinungen
PT04735566T PT1648484E (pt) 2003-06-27 2004-06-01 Formulações para o tratamento de distúrbios artríticos
IL172773A IL172773A (en) 2003-06-27 2005-12-22 Formulations for the treatment of arthritis conditions
NO20056161A NO333877B1 (no) 2003-06-27 2005-12-23 Formuleringer for behandling av artritt-tilstander og anvendelse av en kombinasjon derav

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001311A ITMI20031311A1 (it) 2003-06-27 2003-06-27 Formulazioni per il trattamento di disturbi artrosici.

Publications (2)

Publication Number Publication Date
ITMI20031311A0 true ITMI20031311A0 (it) 2003-06-27
ITMI20031311A1 ITMI20031311A1 (it) 2004-12-28

Family

ID=30131307

Family Applications (1)

Application Number Title Priority Date Filing Date
IT001311A ITMI20031311A1 (it) 2003-06-27 2003-06-27 Formulazioni per il trattamento di disturbi artrosici.

Country Status (21)

Country Link
US (1) US8343554B2 (it)
EP (1) EP1648484B1 (it)
JP (1) JP2007513051A (it)
KR (2) KR101119418B1 (it)
CN (1) CN1812802A (it)
AT (1) ATE414526T1 (it)
AU (1) AU2004253242B2 (it)
BR (1) BRPI0411895B1 (it)
CA (1) CA2530494C (it)
DE (1) DE602004017871D1 (it)
DK (1) DK1648484T3 (it)
ES (1) ES2315662T3 (it)
IL (1) IL172773A (it)
IT (1) ITMI20031311A1 (it)
NO (1) NO333877B1 (it)
NZ (1) NZ544400A (it)
PL (1) PL1648484T3 (it)
PT (1) PT1648484E (it)
RU (1) RU2349336C2 (it)
SI (1) SI1648484T1 (it)
WO (1) WO2005002611A1 (it)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20040439A1 (it) * 2004-09-16 2004-12-16 Ca Di Group S R L Prodotto con azione antinfiammatoria selettiva e azione contro la fibrogenesi tissutale.
ITMI20051349A1 (it) * 2005-07-14 2007-01-15 Indena Spa Estratto di salice uso e formulazioni che lo contengono
CN100417415C (zh) * 2006-06-28 2008-09-10 文彦春 浸润治疗关节炎的药物
EP1886712A1 (en) * 2006-08-08 2008-02-13 Indena S.P.A. Compositions for the treatment of chronic degenerative inflammatory conditions
FR2907339B1 (fr) * 2006-10-20 2009-04-24 Inneov Lab Composition comprenant de la glucosamine et au moins un polyphenol.
CN101371823B (zh) * 2007-03-19 2010-09-15 上海慈瑞医药科技有限公司 二乙酰大黄酸缓释胶囊的制备工艺
FR2918376B1 (fr) 2007-07-04 2011-10-28 Mathieu Borge Compositions liquides ou pateuses destinees a l'apport en elements essentiels a la synthese et a la constitution des proteoglycanes, notamment pour le traitement de la degradation du cartilage
EP2182967A1 (en) * 2007-09-04 2010-05-12 Catholic University Industry Academic Cooperation Foundation Process for preparing vitis vinifera pip extract and pharmaceutical composition for preventing or treating rheumatoid arthritis comprising the same
BRPI0913499B1 (pt) 2008-09-15 2020-03-17 Laila Nutraceuticals Composições anti-inflamatórias sinergísticas compreendendo extratos de boswellia serrata
KR101096574B1 (ko) * 2008-12-12 2011-12-20 에이치 엘 지노믹스(주) 유럽종 포도의 씨 추출물을 함유하는 골다공증 예방 또는 치료용 약학 조성물
KR101099021B1 (ko) * 2009-04-24 2011-12-28 에이치 엘 지노믹스(주) 유럽종 포도의 씨 추출물을 함유하는 골관절염 예방 또는 치료용 약학 조성물
JP5734578B2 (ja) * 2009-09-03 2015-06-17 ナガセケムテックス株式会社 ヒアルロン酸増量剤
EP2515693A1 (en) * 2009-12-23 2012-10-31 Bae Systems Aerospace And Defense Group, INC. Quick release buckle with dual release
RU2578025C2 (ru) 2010-02-15 2016-03-20 Лайла Ньютрасьютикалз Новый низкополярный экстракт камеде-смолы boswellia и его синергетические композиции
US8828377B2 (en) 2010-03-15 2014-09-09 Laila Nutraceuticals Boswellia oil, its fractions and compositions for enhancing brain function
US11123364B2 (en) 2011-06-21 2021-09-21 Bvw Holding Ag Medical device comprising boswellic acid
RU2476213C1 (ru) * 2012-02-15 2013-02-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежская государственная медицинская академия имени Н.Н. Бурденко Министерства здравоохранения и социального развития" (ГБОУ ВПО ВГМА им. Н.Н. Бурденко Минздравсоцразвития России) Способ комплексного лечения вторичного остеоартроза при ревматоидном артрите
JP6270362B2 (ja) * 2013-07-17 2018-01-31 日本水産株式会社 関節痛改善剤
JP6153436B2 (ja) * 2013-09-27 2017-06-28 小林製薬株式会社 経口組成物
US9975917B1 (en) 2017-09-20 2018-05-22 King Saud University Pentacyclic triterpenoidal derivatives
CN111110863A (zh) * 2020-01-21 2020-05-08 郑州大学 大黄酸磷脂复合物及其制备方法和应用、大黄酸磷脂复合物长循环脂质体及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3970M (it) 1963-11-26 1966-02-28
DE1543307B2 (de) * 1965-06-26 1971-03-18 Ajinomoto Co Ine Tokio Haerten von epoxyharzen
DE3347522A1 (de) * 1983-12-30 1985-07-11 Troponwerke GmbH & Co KG, 5000 Köln N-glycosylierte carbonsaeureamid-derivate als mittel bei der bekaempfung von erkrankungen des rheumatischen formenkreises
DE3602670A1 (de) 1986-01-29 1987-07-30 Speck Ulrich Verwendung von n-acetylglucosamin zur therapie degenerativer gelenkprozesse und verwandter erkrankungen
US5629351A (en) 1995-04-13 1997-05-13 Council Of Scientific & Industrial Research Boswellic acid compositions and preparation thereof
DE19531067A1 (de) 1995-08-23 1997-02-27 Hermann P T Prof Dr Med Ammon Verwendung von Boswelliasäure und ihren Derivaten zur Hemmung der normalen und gesteigerten Leukozytenelastase- oder Plasminaktivität
US5762936A (en) * 1996-09-04 1998-06-09 Biotics Research Corporation Antioxidant derived from lentil and its preparation and uses
JP4153057B2 (ja) 1997-03-10 2008-09-17 中国化薬株式会社 Ｄ−グルクロノラクトンの製造方法
US6107334A (en) * 1998-02-23 2000-08-22 Wake Forest University Dietary control of arachidonic acid metabolism
US6761903B2 (en) * 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
IL146130A0 (en) * 1999-05-14 2002-07-25 Univ California Anti-inflammatory therapy for inflammatory mideated infection
JP2002153294A (ja) * 2000-11-21 2002-05-28 Hayashibara Biochem Lab Inc グルクロン酸類及び／又はｄ−グルクロノラクトンの製造方法とその用途
US6451045B1 (en) * 2001-02-22 2002-09-17 Alsius Corporation Heat exchange catheter having a helically wrapped heat exchanger
US6541045B1 (en) * 2002-01-04 2003-04-01 Nutraceutical Corporation Herbal composition and method for combating inflammation

Also Published As

Publication number Publication date
IL172773A (en) 2010-12-30
BRPI0411895A (pt) 2006-08-29
ATE414526T1 (de) 2008-12-15
PL1648484T3 (pl) 2009-04-30
WO2005002611A1 (en) 2005-01-13
RU2349336C2 (ru) 2009-03-20
US20060280811A1 (en) 2006-12-14
DE602004017871D1 (de) 2009-01-02
US8343554B2 (en) 2013-01-01
KR101119418B1 (ko) 2012-02-22
CA2530494C (en) 2013-04-30
KR20110039400A (ko) 2011-04-15
IL172773A0 (en) 2006-04-10
ES2315662T3 (es) 2009-04-01
JP2007513051A (ja) 2007-05-24
SI1648484T1 (sl) 2009-02-28
RU2005140573A (ru) 2006-06-10
AU2004253242B2 (en) 2010-02-18
KR20060032147A (ko) 2006-04-14
NO333877B1 (no) 2013-10-07
BRPI0411895B1 (pt) 2015-11-10
EP1648484A1 (en) 2006-04-26
EP1648484B1 (en) 2008-11-19
ITMI20031311A1 (it) 2004-12-28
PT1648484E (pt) 2009-01-09
CN1812802A (zh) 2006-08-02
AU2004253242A1 (en) 2005-01-13
NO20056161L (no) 2005-12-23
NZ544400A (en) 2009-04-30
CA2530494A1 (en) 2005-01-13
DK1648484T3 (da) 2009-01-19

Similar Documents

Publication Publication Date Title
CY2013022I1 (el) Συνθεσεις για την θεραπευτικη αγωγη γαστρεντερικων διαταραχων
ITMI20031311A0 (it) Formulazioni per il trattamento di disturbi artrosici
CY2015025I1 (el) Μεθοδοι για την αντιμετωπιση της νοσου παρκινσον
IS7099A (is) Efnasambönd til að meðhöndla bólgutruflanir
NO20043237L (no) Dihydrobenzodiazepin-2-onderivater for behandling av neurologiske forstyrrelser
IS8398A (is) Lyfjasamsetningar til að meðhöndla æxli
IS7691A (is) Lyfjasamsetningar til að meðhöndla æxli
NO20053077D0 (no) Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
ZA200504558B (en) Compounds for the treatment of metabolic disorders
ITMI20020756A0 (it) Composizioni farmaceutiche topiche per il trattamento delle dermatiti
DK1562932T3 (da) 4 tetrazolyl-4-phenylpiperidinderivater til behandling af smerter
NO20055098D0 (no) Anvendelse av 10-hydroksy-10,11-dihydrokarbamazepinderivater for behandling av affektive forstyrrelser
GB0329874D0 (en) Compounds useful for the treatment of diseases
DE502004010131D1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
NO20033803D0 (no) Karbamat for behandling av bevegelseslidelser
IL175412A0 (en) Use of specific histones for the treatment of parasitic diseases
DK1727801T3 (da) Til behandling af smerter anvendelige piperaziner
ITMI20031994A1 (it) Procedimento per la preparazione di fludarabina fosfato
IS8225A (is) 2-etoxý-3-fenýlprópíónsýruafleiður til að meðhöndla fitusjúkdóma
ITMI20030018A1 (it) Procedimento per la preparazione di composti mono-
ITMI20050891A1 (it) Formulazioni per il trattamento di psoriasi
ITMI20030019A1 (it) Procedimento per la preparazione di composti mono-
ITRM20030442A0 (it) Composizione farmaceutica (stressen) per il trattamento di iperomocisteinemia.
ITMI20022263A1 (it) Composizioni per il trattamento delle emorroidi.
DK1594498T3 (da) Anvendelse af etazolat til behandling af sygdomme